Boston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BEIJING, Jan 17 (APP): The memorandums of understanding (MoUs) worth around $1.6 billion were signed at the China-Pakistan ...

Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, ...

Boston Scientific Corp. is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder ...

Two teens were transported to Harborview Medical Center.

Global Brain Ischemia market Size, Share & Trends Analysis Report By treatment (Angioplasty, Beta Blockers, Angiotensin-Converting Enzyme (ACE) In ...

Under the Health Silk Road, Beijing has embedded itself as a ... new healthcare infrastructure and greater access to medical technology, that I don’t see much in the way of concern about ...